An international leader in his field, Dr Stuart Callary is celebrating international success for his hip replacement research.
Dr Callary and the orthopaedics team across the Royal Adelaide Hospital, University of Adelaide and Flinders University are hitting major milestones.
They are one of the few groups in the world to use accurate software measurements of implant stability that identifies poor-performing hip implants earlier. This then allows for earlier interventions.
His work has been globally recognised after receiving the 2024 Orthopaedic Research Society’s Harris Award in California! This is an incredible achievement for life-changing research! Dr Callary’s work is proudly supported by The Hospital Research Foundation Group.
Dr Callary said the award was special to his team because the Orthopaedic Research Society is the largest dedicated group focussed on improving musculoskeletal health in the world.
“For our team to be recognised with this award is extremely encouraging for our ongoing studies,” Dr Callary said.
“This award generated a lot of interest when we were in California, and it was fantastic to hear that many people are keenly awaiting results of our larger cohort.
“A constant point of discussion was the unique multidiscipline approach of our team which is made up of clinicians, scientists, biomechanical and engineering experts.
“Without this collaborative expertise, our study simply would not be possible.”
Improving outcomes for hip replacement patients
So far, the team has over 200 patients enrolled in their clinical trials of primary and revision hip replacements.
The results of the teams’ trial enhances the implant performance and longevity for over 50,000 hip replacement patients per year in Australia alone.
Looking towards the future
The team have exciting plans in the future! They will be working with their collaborators to build patient specific computer models to test the effectiveness of new implants.
“Testing the performance of hip implants before its used reduces the risk of patients receiving poor performing implants,” Dr Callary said.
“In more complex cases, it may improve the longevity of the implant.”
Continuing the journey of innovation
We’re excited to share updates on Dr Callary’s research journey as he and his team push boundaries of orthopaedic care.
